Diabetes medication(s)-Non-insulin oral drugs Posts on Medivizor
Navigation Menu

Diabetes medication(s)-Non-insulin oral drugs Posts on Medivizor

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Posted by on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of teneligliptin (Tenelia) to placebo in patients with type 2 diabetes (T2D) that was inadequately controlled with triple oral antidiabetic drugs (OADs). The study showed that teneligliptin may be considered as a fourth add-on OAD treatment in these patients. Some background T2D is...

Read More

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Posted by on Jun 26, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of a ketogenic diet mobile health application (Keyto app) with breath acetone biofeedback (device) versus a calorie-restricted, low-fat diet (WW; weight watchers) app on weight loss and metabolic risk in patients with overweight or obesity. The data showed that a ketogenic diet app with a breath acetone...

Read More

Comparing chiglitazar and sitagliptin effectiveness on glucose variations, insulin resistance and inflammation levels in patients with type 2 diabetes.

Comparing chiglitazar and sitagliptin effectiveness on glucose variations, insulin resistance and inflammation levels in patients with type 2 diabetes.

Posted by on Feb 13, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness of chiglitazar (Bilessglu) and sitagliptin (Januvia) on glycemic (blood glucose) variations, insulin resistance, and inflammation levels in patients with type 2 diabetes (T2D). The data showed that chiglitazar treatment was more effective at improving insulin resistance and inflammation compared...

Read More

Can SGLT2 inhibitors prevent liver disease for people with diabetes?

Can SGLT2 inhibitors prevent liver disease for people with diabetes?

Posted by on Aug 7, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at whether sodium-glucose cotransporter 2 (SGLT2) inhibitors can improve non-alcoholic fatty liver disease (NAFLD) for people with type 2 diabetes (T2D). It found that these medications can improve liver function in these patients. Some background NAFLD is a condition in which fat builds up in the liver. This makes the...

Read More

Reduced risk of heart failure hospitalizations in patients with type 2 diabetes using SGLT-2 inhibitors

Reduced risk of heart failure hospitalizations in patients with type 2 diabetes using SGLT-2 inhibitors

Posted by on Feb 28, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review focused on the effect of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) on heart failure hospitalization in patients with type 2 diabetes (T2D). This analysis showed that SGLT-2is may reduce the risk of heart failure hospitalizations in these patients. Some background Patients with T2D have a higher risk of developing...

Read More

Do SGLT2 inhibitors with or without metformin improve heart and kidney health?

Do SGLT2 inhibitors with or without metformin improve heart and kidney health?

Posted by on Nov 29, 2020 in Diabetes mellitus | 0 comments

In a nutshell This review looked at how SGTL2 inhibitors with or without metformin (Glucophage) affect heart and kidney health for patients with type 2 diabetes (T2D). It found that these medications improve cardiovascular and kidney outcomes, whether or not patients are also taking metformin. Some background SGLT2 inhibitors are a group of T2D...

Read More

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Evaluating the safety and effectiveness of polyethylene glycol loxenatide in patients with T2D

Posted by on Sep 20, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D). It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients. Some background T2D is a...

Read More

Evaluating combination therapy versus metformin only for patients with Type 2 diabetes

Posted by on Nov 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether adding vildagliptin (Galvus) to metformin (Glucophage) could improve the duration of blood glucose control for patients with newly diagnosed Type 2 Diabetes (T2D). The authors found that this treatment combination improved long-term blood glucose control for these patients. Some background...

Read More

Is IDegLira more effective than degludec or liraglutide alone for treating uncontrolled Type 2 diabetes?

Posted by on Sep 16, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared IDegLira (Xultophy) to insulin degludec (Tresiba) or liraglutide (Victoza) alone in patients with uncontrolled Type 2 diabetes (T2D). The authors concluded that combined IDegLira was more effective and had fewer side effects than either insulin medication alone. Some background One of the main...

Read More

Is IDegLira more effective than standard insulin for patients with Type 2 diabetes?

Posted by on Sep 4, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared insulin degludec/liraglutide (IDegLira) to standard insulin in patients with uncontrolled Type 2 diabetes (T2D).  The authors concluded that IDegLira improved patient compliance to treatment and reduced treatment-related stress compared to conventional insulin. Some background One of the main goals of treatment...

Read More

Can nutritional supplements help reduce hypoglycemia in patients with Type 2 diabetes?

Posted by on Sep 1, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if nutritional supplements can reduce the rate of hypoglycemia in patients with Type 2 diabetes (T2D). This study concluded that these supplements helped reduce hypoglycemia and lowered mortality risk for these patients. Some background Treatment for T2D, such as insulin, can cause blood sugar levels to...

Read More